Medication info
Glyflo Tablet 10 mg (Dapagliflozin Propanediol Hydrate)

Glyflo Tablet 10 mg (Dapagliflozin Propanediol Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Dapagliflozin Propanediol Hydrate›12.3mg / 1 tablet
Manufacturer / importer
Daewoo Pharmaceutical Co., Ltd.
Appearance
Yellow, biconvex, diamond-shaped film-coated tablet
Packaging
30 tablets/bottle, 90 tablets/bottle
Approval status
Active

MFDS item code 202204126 · Approved 2022.11.16 · Insurance code 649606220

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults · Children
Adult dose
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, including insulin. When this medicine is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received antidiabetic drug therapy, the recommended initial dose of this medicine when administered in combination with metformin is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR below 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, a starting dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Older adults (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be administered orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
Child dose
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Ingredients

Manufacturer
Daewoo Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

View approved original text

This medication helps patients with type 2 diabetes control their blood sugar more effectively. It can be used alone or in combination with other medications alongside dietary and exercise therapy. It is particularly applicable to patients whose blood sugar is not adequately controlled and who have cardiovascular diseases or risk factors. Thus, it aids not only in blood sugar management but also in considering the possibility of cardiovascular events. Therefore, it is effectively used for blood sugar control and the prevention of complications in type 2 diabetes.

How to take

Adult dose

Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, including insulin. When this medicine is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received antidiabetic drug therapy, the recommended initial dose of this medicine when administered in combination with metformin is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR below 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, a starting dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Older adults (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be administered orally once daily at any time of day, with or without food. The tablet should be swallowed whole.

Child dose

The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Precautions

This medication should not be used in certain patients. For example, it should not be administered to patients allergic to this medication, patients with type 1 diabetes, diabetic ketoacidosis, congenital disorders like lactose intolerance, and patients undergoing dialysis. In patients with reduced fluid volume or impaired kidney function, this medication should be used with caution. It may lower blood pressure or affect kidney function, so fluid status and kidney function should be carefully monitored before and after administration. Side effects such as genital infections, urinary tract infections, hypoglycemia, reduced fluid volume, and ketoacidosis may occur while taking this medication. In particular, women or patients with a history of infections may experience genital infections more frequently. Additionally, while this medication helps with blood sugar control, its effectiveness may be reduced in patients with severely impaired kidney function. Pregnant or breastfeeding women are advised not to take this medication and should discontinue it immediately if pregnancy is confirmed. This medication may interact with other drugs, so when used in conjunction with diuretics or insulin, dosage adjustments may be necessary to reduce the risk of hypoglycemia or dehydration. In case of overdose, there is no specific antidote, so appropriate treatment based on symptoms should be sought, and methods for removing this medication through dialysis are not known. Finally, care should be taken while driving or operating machinery during the course of this medication, especially when taken with insulin or sulfonylureas, to always be aware of the risk of hypoglycemia. The safety and efficacy of this medication in children have not been established, making its use inadvisable in this population. It is important to always follow the instructions of a physician or pharmacist and consult immediately if any abnormal symptoms occur.

Side effects

Vulvovaginitis, balanitis and related genital infections, urinary tract infections, fungal infections, perineal necrosis, hypoglycemia, decreased fluid volume, thirst, diabetic ketoacidosis, dizziness, constipation, dry mouth, low back pain, dysuria, polyuria, nocturia, interstitial nephritis, vulvar itching, genital itching, elevated hematocrit, initial treatment decreased renal creatinine clearance, dyslipidemia, initial treatment increased serum creatinine, elevated serum urea, weight loss, acute pyelonephritis, rash, angioedema, fatigue, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebral hemorrhage, peripheral artery occlusion, angina, myocardial infarction, choledocholithiasis, cholangitis, alcoholic cirrhosis, depression, suicide attempt, gastric adenocarcinoma, anaphylactic reaction, chest pain, paresthesia, headache, dyspepsia, nausea, diarrhea, vomiting, urinary retention, alanine aminotransferase increase, aspartate aminotransferase increase, decreased appetite, next symptom, headache, nasopharyngitis, upper respiratory infection, chest pain, fatigue, chest discomfort, peripheral edema, generalized edema, hunger, vaginal discharge, menstrual irregularities, itching, urticaria, diaphoresis, arthralgia, musculoskeletal pain, limb pain, muscle weakness, myalgia, osteoarthritis, ligament sprain, diabetic retinopathy, cough, shortness of breath, orthostatic hypotension, palpitations, insomnia, fatty liver, gallbladder polyp, tinnitus

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to avoid exposure to air and moisture. It is best to keep the medication at room temperature between 1 and 30 degrees Celsius, away from extreme heat or cold.

Appearance and packaging

Appearance

Yellow, biconvex, diamond-shaped film-coated tablet

Package unit

30 tablets/bottle, 90 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.